placeen-us
Contact Us
Animal Health / Products / Veterinary Electrosurgical Hardware / Valleylab™ FT10 Animal Health Energy Platform

Overview

It takes trust to advance

For over 50 years, the Valleylab™ portfolio has shown an unwavering commitment to positive patient outcomes through trusted energy delivery, establishing pathways for future innovation in the surgical energy space.

Our proprietary electronics and algorithms allow the Valleylab™ FT10 energy platform to deliver the highest power consistency.†,‡,1,2

FEATURES

The Valleylab™ FT10 animal health energy platform delivers precise and consistent tissue effects with LigaSure™ and electrosurgical devices.3 TissueFect™ sensing technology adjusts energy output in real time by actively monitoring tissue impedance changes and delivering the appropriate amount of energy for the desired tissue effect.3

Performance improvements

LigaSure™ technology is improved with:

  • Up to 50% faster sealing times§,◊,4
  • Lower jaw temperatures◊,¶,5

Electrosurgical performance is more precise:

  • Autobipolar has a faster activation time◊,#,6
  • Monopolar performance is improved◊,7
  • Bipolar resection performance is improved◊,∆,7
Order Information
Order Code Description Unit of Measure Quantity
VLFT10GENAH Valleylab™ FT10 Animal Health Energy Platform Each 1
VLFTCRT Valleylab™ FT10 Cart Each 1
Order Information
Order Code Description Unit of Measure Quantity
VLFT10GENAH Valleylab™ FT10 Animal Health Energy Platform Each 1
VLFTCRT Valleylab™ FT10 Cart Each 1
  • † In-vivo porcine testing model used to statistically evaluate activation time, hemostasis, and thermal spread. Bench burst on fresh porcine renal arteries used to statistically evaluate burst pressures.
  • ‡ Compared to the Force Triad™ energy platform.
  • § Bench testing model used to evaluate burst pressure of renal arteries. May not be indicative of clinical performance. Using LigaSure™ devices LF1212A, LF1637, LF4318, and LS1037.
  • ◊ As compared with the ForceTriad™ energy platform.
  • ¶ Testing performed using porcine model to find average jaw temperature. Tissue types included small bowel mesentery using LigaSure™ devices LF1212A, LF1637, LF4318, and LS1037.
  • # Ex-vivo testing model used to evaluate average additional activation delay time compared between the ForceTriad™ and the Valleylab™ FT10. There is a statistically significant difference between the two generators (p = 0.033) with the Valleylab™ FT10 having lower activation time delays than the ForceTriad™.
  • ∆ 31 of 32 surgeons agreed.
  • 1. Based on internal report #RE00005503 rev C, Verification report GLP acute animal lab: LigaSure™ preclinical evaluation of Valleylab™ FT10. May 19, 2015.
  • 2. Based on internal report #R0064457 rev A, Verification report LigaSure™ renal bench burst pressure evaluation of the Valleylab™ FT10. May 3, 2015.
  • 3. Based on internal memo #RE00256209 rev A, Valleylab™ FT10 memo control system resolution in VLFT10GEN. March 2020.
  • 4. Based on internal memo #RE00025819 rev A, LigaSure™ data sources for VLFT10 white papers. September 2015.
  • 5. Based on internal report #R0064462 rev B, LigaSure™ thermal profile Valleylab™ FT10. June 2016.
  • 6. Based on internal report #R0064455 rev B, Autobipolar Evaluation of the Valleylab™ FT10. May 2015.
  • 7. Based on internal report #RE00005401 rev A, Product validation of Valleylab™ FT10 surgeon & nurse evaluation in simulated use. January–February 2015.
Corporate Resources
Medtronic Animal Health
Contact Us
Operational Headquarters

710 Medtronic Parkway

Minneapolis, MN

55432-5604

USA

©2025 Medtronic